TICKERNERD
Menu
IRTCIRTCHealthcare · Medical Devices

IRTC Stock Forecast: iRhythm Holdings, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$126
+2.66% on the day

The 15 Wall Street analysts covering iRhythm Holdings, Inc. hold a median 12-month price target of $178 — +40.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 15 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$4.2B
Ticker Nerd rank
78 / 100
Median analyst target
$178
Analysts covering
15
Total return, dividends reinvested
1W
−1.1%
1M
+12.3%
YTD
−28.7%
1Y
−22.0%
From 52W high
−33.2%
From 52W low
+24.2%
$102
$189
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

IRTC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores iRhythm Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
92
Growth
88
Accruals
69
Volatility
68
Issuance
65
Revisions
63
Value
57
Momentum
37
Size
27

Quality (92): The business earns solid, repeatable profits on what it owns.

Momentum (37): The shares have been drifting down relative to others.

Size (27): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

IRTC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on IRTC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$120$140$160$180$200Oct 25Jan 26Apr 26Jul 26IRTCHigh $200Median $178Low $157

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says15 analysts
15 Buy0 Hold0 Sell
Low $157Median $178High $200

The green dot is the last close — the median target sits +40.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
10 Aug 2026Truist SecuritiesMaintainsBuy$160 → $168
7 Aug 2026Evercore ISI GroupMaintainsOutperform$150 → $165
7 Aug 2026NeedhamMaintainsBuy$255 → $192
7 Aug 2026Wells FargoMaintainsOverweight$180 → $168
23 July 2026Stephens & Co.InitiatesOverweight$160
23 July 2026Stephens & Co.InitiatesOverweight—
16 July 2026Truist SecuritiesMaintainsBuy—
16 July 2026Truist SecuritiesMaintainsBuy$174 → $160
6 July 2026Evercore ISI GroupMaintainsOutperform—
22 June 2026BTIGReiteratesBuy—
10 June 2026BTIGReiteratesBuy—
1 June 2026Canaccord GenuityMaintainsBuy—
18 May 2026B of A SecuritiesMaintainsBuy—
4 May 2026CitigroupMaintainsBuy—
1 May 2026Canaccord GenuityMaintainsBuy—
1 May 2026Evercore ISI GroupMaintainsOutperform—
1 May 2026JP MorganMaintainsOverweight—
1 May 2026NeedhamMaintainsBuy—
1 May 2026Wells FargoMaintainsOverweight—
15 Apr 2026Truist SecuritiesMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. IRTC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

IRTC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+357.5%
Analysts raising
0
Analysts cutting
1
Fundamentals

iRhythm Holdings, Inc. (IRTC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−91.0×

Cheaper than 99% of US stocks

Price / sales
5.0×

Cheaper than 25% of US stocks

Price / book
25.8×

Cheaper than 4% of US stocks

EV / EBITDA
243.2×

Cheaper than 1% of US stocks

Growth & margins
Revenue growth (YoY)
20.1%

Higher than 70% of US stocks

Earnings growth (YoY)
20.1%

Higher than 59% of US stocks

Gross margin
72.8%

Higher than 85% of US stocks

Operating margin
7.9%

Higher than 60% of US stocks

Net margin
−1.7%

Higher than 28% of US stocks

Returns & dividend
Return on equity
−9.6%

Higher than 36% of US stocks

Return on assets
0.6%

Higher than 47% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

IRTC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
IRTCiRhythm Holdings, Inc.$4.2B
78
HAEHaemonetics Corp.$4.3B
99
ITGRInteger Holdings Corp.$4.4B
71
LIVNLivaNova PLC$4.5B
97
TMDXTransMedics Group, Inc.$3.1B
29
AXGNAxoGen, Inc.$2.6B
78
NEOGNeogen Corp.$2.5B
96

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own iRhythm Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest IRTC news & analysis

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 17 Aug 2026negative

A law firm is investigating whether insiders at iRhythm Technologies, Inc. breached their fiduciary duties to shareholders. The firm is encouraging shareholders to contact them at no cost about their legal rights and options.

Why it matters — IRTC watchers would care because the notice points to a potential shareholder investigation or legal action concerning insider conduct at the company.

iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform

Zacks Investment Research · 14 Aug 2026positive

iRhythm Holdings announced plans to acquire VitalConnect, a move that expands its cardiac monitoring platform across ambulatory, inpatient and hospital-to-home care settings. According to the report, the deal opens new growth opportunities for the company.

Why it matters — The acquisition broadens iRhythm's cardiac monitoring capabilities into additional care settings, potentially widening its market reach for investors tracking the company.

Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock

Zacks Investment Research · 14 Aug 2026positive

Zacks Investment Research highlighted iRhythm Holdings (IRTC) as a strong momentum stock, using its Zacks Style Scores feature from the Zacks Premium research service to identify the stock among value, growth, and momentum options.

Why it matters — An IRTC watcher would note that the company is being recognized by a major research service for strong momentum characteristics, which can signal heightened investor attention.

iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised

Zacks Investment Research · 10 Aug 2026positive

iRhythm reported Q2 earnings that beat estimates, driven by volume growth, with 20.1% revenue growth and margin expansion. The company also raised its 2026 outlook while advancing innovation and its Vital Connect acquisition.

Why it matters — IRTC watchers would note that the company beat earnings expectations on volume growth, raised its 2026 outlook, and continues progressing on its Vital Connect acquisition and innovation efforts.

iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care

Benzinga · 7 Aug 2026positive

iRhythm Holdings agreed on Thursday to acquire Vital Connect, Inc., a privately held developer of wearable biosensor technology. The acquisition is aimed at expanding iRhythm's remote cardiac care capabilities.

Why it matters — IRTC watchers would care because the acquisition of Vital Connect could broaden iRhythm's wearable biosensor technology and expand its remote cardiac care offerings.

FAQ

Frequently asked questions about IRTC stock

What is the IRTC stock price forecast for 2026-2027?

The 15 Wall Street analysts covering iRhythm Holdings, Inc. have a median 12-month price target of $178, with estimates ranging from $157 to $200. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is IRTC stock a buy right now?

Of the 15 analysts covering iRhythm Holdings, Inc., 15 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks iRhythm Holdings, Inc. 78 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank IRTC?

As at 15 Aug 2026, iRhythm Holdings, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (92 of 100).

Will IRTC stock go up?

No one can know that. What the data says: the median 12-month target from 15 analysts implies +40.4% from the last close, and Ticker Nerd's factor model ranks iRhythm Holdings, Inc. 78 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the IRTC stock forecast for 2030?

No analyst covering iRhythm Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IRTC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $157 to $200 over the next 12 months.

How has IRTC stock performed over the past year?

iRhythm Holdings, Inc. returned -22.0% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does iRhythm Holdings, Inc. do?

iRhythm Technologies Inc. is a leading digital healthcare company that develops and commercializes wearable biosensors and cloud-based analytics for detecting, predicting, and preventing cardiac diseases.

What is the latest news on IRTC?

The most recent item we track (PRNewsWire, 17 Aug 2026): "Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?". A law firm is investigating whether insiders at iRhythm Technologies, Inc. breached their fiduciary duties to shareholders. The firm is encouraging shareholders to contact them at no cost about their legal rights and options.

Company

About iRhythm Holdings, Inc.

iRhythm Technologies Inc. is a leading digital healthcare company that develops and commercializes wearable biosensors and cloud-based analytics for detecting, predicting, and preventing cardiac diseases. Its flagship Zio platform features an FDA-cleared, CE-marked, wire-free patch-based biosensor that records up to 14 days of continuous electrocardiogram (ECG) data, paired with proprietary AI-driven software that analyzes millions of heartbeats to deliver actionable clinical insights for diagnosing arrhythmias more efficiently than traditional methods. The Zio system supports ambulatory cardiac monitoring, including long-term continuous monitoring (LTCM) and mobile cardiac telemetry, enabling faster detection of conditions like atrial fibrillation across diverse patient populations, including those with cardio-kidney-metabolic diseases. iRhythm Technologies Inc. serves clinicians through services that emphasize patient-centric design, such as home self-application, high analyzable ECG time, and real-world evidence from large-scale studies. Operating in the U.S. core market, innovative channels, and internationally, the company plays a key role in advancing ambulatory ECG monitoring and data-driven cardiac diagnostics.

CEO Mr. Quentin S. Blackford · 2,400 employees · United States · https://www.irhythmtech.com